Welcome to our dedicated page for So-Young Intl news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young Intl stock.
So-Young International Inc. (SY) operates China's leading digital platform for medical aesthetics discovery and reservations. This news hub provides investors and industry observers with essential updates about the company's operational developments, strategic partnerships, and market position within the evolving healthcare services sector.
Track official press releases covering quarterly earnings, technology initiatives, and provider network expansions alongside curated analysis of SY's unique vertical integration model. Our repository includes updates on:
• Financial disclosures including SEC filings and earnings call details
• Strategic collaborations with medical equipment manufacturers and clinics
• Platform enhancements to its social community and booking systems
• Regulatory developments affecting China's medical aesthetics sector
Bookmark this page for streamlined access to verified information about SY's dual role as both digital content curator and physical service facilitator in the $10B+ Chinese medical beauty market. Check regularly for updates on how the company maintains its competitive edge through vetted provider networks and data-driven consumer insights.
So-Young International Inc. (NASDAQ: SY), China's largest social community for medical aesthetics, has announced it will report its Q2 2024 financial results on August 23, 2024, before U.S. markets open. The company will hold an earnings conference call at 7:30 AM U.S. Eastern Time (7:30 PM Beijing/Hong Kong Time) on the same day. Dial-in details for international, China, US, and Hong Kong participants are provided, along with a passcode. A telephone replay will be available until August 30, 2024. Additionally, a live and archived webcast of the conference call will be accessible at http://ir.soyoung.com.
So-Young International (Nasdaq: SY) reported financial results for Q1 2024. The company's total revenues increased to RMB318.3 million (US$44.1 million), a 2.6% rise year-over-year. However, the net loss rose to RMB21.2 million (US$2.9 million), compared to a net loss of RMB11.9 million in Q1 2023. Non-GAAP net income was RMB4.1 million (US$0.6 million), contrasting a non-GAAP net loss of RMB2.8 million the previous year.
Operational highlights include a drop in average mobile MAUs to 2.0 million from 3.4 million and a decrease in medical service providers on the platform to 1,160 from 1,419. Despite this, sales of medical products and maintenance services surged 23.3% to RMB86.5 million (US$12.0 million). The company also noted a significant increase in general and administrative expenses by 38.1%.
Looking forward, So-Young expects Q2 2024 revenues between RMB380.0 million (US$52.6 million) and RMB400.0 million (US$55.4 million), reflecting a potential year-over-year decrease.
So-Young International (NASDAQ: SY), a leading social community in China's medical aesthetics industry, announced it will report its Q1 2024 financial results on May 28, 2024. The announcement will be made before U.S. markets open. An earnings conference call is scheduled for the same day at 7:30 AM U.S. Eastern Time (7:30 PM Beijing/Hong Kong Time). Interested parties can dial in using provided international, U.S., China, and Hong Kong numbers. A replay will be available until June 4, 2024. A live and archived webcast will also be accessible at So-Young's investor relations website.
